FDA Approves RU-486
WASHINGTON - The Food and Drug Administration (FDA) approved the abortion pill RU-486. Within a month, doctors will be able to prescribe the drug Mifeprex, or mifepristone, for women who are as much as seven weeks pregnant.
Despite warnings that the FDA would impose limitations on doctors who offer the pill, yesterdays approval came with relatively minor restrictions. The rules given require that doctors who prescribe Mifeprex be able to determine how far along a pregnancy is and must either be able to perform surgical abortions or have a pre-existing agreement with another physician who is qualified to conduct such surgery. For more information visit www.fda.gov.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
